| Literature DB >> 26432889 |
Aiko Sato-Otsubo1, Yasuhito Nannya2, Koichi Kashiwase3, Makoto Onizuka4, Fumihiro Azuma3, Yoshiki Akatsuka5, Yasuko Ogino6, Masahiro Satake3, Masashi Sanada1, Shigeru Chiba7, Hiroh Saji8, Hidetoshi Inoko4, Giulia C Kennedy9, Ken Yamamoto10, Satoko Morishima11, Yasuo Morishima12, Yoshihisa Kodera13, Takehiko Sasazuki14, Seishi Ogawa1.
Abstract
Acute graft-versus-host disease (aGVHD) represents one of the major complications in allogeneic stem cell transplantation and is primarily caused by genetic disparity between the donor and recipient. In HLA-matched transplants, the disparity is thought to be determined by loci encoding minor histocompatibility antigens (minor H antigens), which are presented by specific HLA molecules. We performed a genome-wide association study (GWAS) to identify minor H antigen loci associated with aGVHD. A total of 500 568 single nucleotide polymorphisms (SNPs) were genotyped for donors and recipients from 1589 unrelated bone marrow transplants matched for HLA-A, -B, -C, -DRB1, and -DQB1, followed by the imputation of unobserved SNPs. We interrogated SNPs whose disparity between the donor and recipient was significantly associated with aGVHD development. Without assuming HLA unrestriction, we successfully captured a known association between HLA-DPB1 disparity (P = 4.50 × 10(-9)) and grade II-IV aGVHD development, providing proof of concept for the GWAS design aimed at discovering genetic disparity associated with aGVHD. In HLA-restricted analyses, whereby association tests were confined to major subgroups sharing common HLA alleles to identify putative minor H antigen loci, we identified 3 novel loci significantly associated with grade III-IV aGVHD. Among these, rs17473423 (P = 1.20 × 10(-11)) at 12p12.1 within the KRAS locus showed the most significant association in the subgroup, sharing HLA-DQB1*06:01. Our result suggested that a GWAS can be successfully applied to identify allele mismatch associated with aGVHD development, contributing to the understanding of the genetic basis of aGVHD.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26432889 DOI: 10.1182/blood-2015-03-630707
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113